Boi, M., Todaro, M., Vurchio, V., Yang, S. N., Moon, J., Kwee, I., . . . Inghirami, G. (2016). Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: An alternative modality to overcome resistant phenotypes. Oncotarget.
Trích dẫn kiểu ChicagoBoi, Michela, et al. "Therapeutic Efficacy of the Bromodomain Inhibitor OTX015/MK-8628 in ALK-positive Anaplastic Large Cell Lymphoma: An Alternative Modality to Overcome Resistant Phenotypes." Oncotarget 2016.
Trích dẫn MLABoi, Michela, et al. "Therapeutic Efficacy of the Bromodomain Inhibitor OTX015/MK-8628 in ALK-positive Anaplastic Large Cell Lymphoma: An Alternative Modality to Overcome Resistant Phenotypes." Oncotarget 2016.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.